Search results
Migraine med might stop 'rebound' headaches as well
United Press International via Yahoo Canada News· 6 days agoResearchers noted that one limitation of the study is that participants self-reported their headaches and medication use, raising the possibility that...
Euronext Paris Growth Leaders With High Insider Ownership And Up To 101% Earnings Growth
Simply Wall St. via Yahoo Finance Canada· 5 days agoAmidst a backdrop of broad gains across European markets, with France's CAC 40 Index notably...
Should Pacer US Cash Cows 100 ETF (COWZ) Be on Your Investing Radar?
Zacks via Yahoo Finance Canada· 6 days agoConsumer Discretionary and Healthcare round out the top three. Looking at individual holdings,...
NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
Digital Journal· 5 days agoNurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, is pleased to announce a pre-clinical study to explore ...
TVM Capital Healthcare invests $35m in Saudi generics and biosimilars
BioPharma-Reporter· 6 days agoThe Dubai and Singapore-based investor’s cash is aimed to accelerate the plans of Boston Oncology Arabia to move into full formulation and fill and finish manufacturing at its local facilities ...
FDA Approves Skyrizi for Ulcerative Colitis
AOL· 5 days agoThe FDA has approved Skyrizi, a drug already used to address psoriasis and Crohn’s disease, for the treatment of ulcerative colitis. Ulcerative colitis is a chronic inflammatory bowel disease ...
LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders
Digital Journal· 5 days agoBOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to ...
